This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
“I would have never, ever in my whole life have said, ‘we’re going to cure…
Dr. Betancourt, president of the influential The Commonwealth Fund, is committed to “Affordable, quality health…
President Trump signed the “One Big Beautiful Bill Act” into law on July 4 and…
ENCORE - Originally aired November 7, 2024 There’s a lot of attention right now around…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…
It’s a troubling situation: Nearly one in three high school students report persistent feelings of…